吉非替尼 - CAS:184475-35-2 - Shanghai Nataling Pharmaceutical Technology Co., Ltd.

Gefitinib

Item No.：	NLDP250004
CAS No.：	184475-35-2

Product Name	Gefitinib
Alias	N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine;GEFITINIB;AKOS 91371;n-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine;ZD 1839;4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-;Gefitinib(TINIBS);Gefitinib (ZD1839);Gefitinib (ZD1839, Iressa®);Iressa;N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; Irressat;ZD-1839;Gefinitib;Getfitnib;Gifitinib;Ji Fei Ji;Gefitinib WS;ZD1839;Gefitinib, >=99%;Gefitinib iMpurity;N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine;4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline;N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholiny;N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4;DTXSID8041034;C22H24ClFN4O3;KS-1204;D01977;Kinome_3322;(3-CHLORO-4-FLUORO-PHENYL)-[7-METHOXY-6-(3-MORPHOLIN-4-YL-PROPOXY)-QUINAZOLIN-4-YL]-AMINE;184475-35-2;Gefitinib,ZD-1839,Iressa;Q417824;SR-00000000262-2;BG164498;Iressa (AstraZeneca);AB01273954-01;BRD-K64052750-001-23-3;Z1546610485;gefitinibum;HMS3714A05;Kinome_3321;HMS3295A21;Gefitinib (JP18/USAN/INN);DTXCID6021034;SW199108-4;GEFITINIB [EP MONOGRAPH];HY-50895;HMS3748E17;HMS3413H08;SR-00000000262;NCGC00159455-03;CS-0124;GEFITINIB (MART.);BCP01365;HMS3677H08;NCGC00159455-02;N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine;CHEMBL939;NCGC00159455-06;UNII-S65743JHBS;NSC715055;NSC-715055;3-Chloro-4-Fluoro-N-[(4z)-7-Methoxy-6-(3-Morpholin-4-Ylpropoxy)quinazolin-4(1h)-Ylidene]aniline;Q-201149;NSC 759856;HY-50895G;Tox21_111683_1;CAS-184475-35-2;CHEBI:49668;NSC759856;GEFITINIB [INN];G-4408;HMS3244M21;SY002154;4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-(3-morpholinopropoxy)quinazoline;NSC-800105;SDCCGSBI-0634411.P005;NCGC00159455-09;Iressa (TN);CS-0622782;GEFITINIB [WHO-DD];SR-00000000262-3;s1025;Gefitinib, >=98% (HPLC);AB01273954-02;BCP9000718;GTPL4941;CU-00000000396-1;STK621310;Gefitinib (ZD1839)?;SMR002204119;4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-4-morpholin)propoxy)-;HMS3654A07;NS00006312;6-(3-morpholinopropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine;NCGC00159455-14;BRD-K64052750-001-22-5;BCPP000221;DB00317;MLS003899193;BRD-K64052750-001-17-5;NCGC00159455-08;K00240;HMS3244N21;Gefitinib (GMP);AC-1556;SCHEMBL7866;cid_123631;NCGC00159455-04;NSC-759856;G0546;Gefitini; Iressa;IRE;S65743JHBS;BRD-K64052750-001-16-7;GEFITINIB [MI];L01XE02;EN300-123024;HMS3244M22;GEFITINIB [EMA EPAR];GEFITINIB [VANDF];GEFITINIB [ORANGE BOOK];GEFITINIB [MART.];CCG-220642;N-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine;Gefitinib [USAN:INN:BAN];AKOS000280752;Gefitinib, EuropePha...
CAS No.	184475-35-2
Molecular Formula	C22H24CLFN4O3
Molecular Weight	446.90
Density	1.322
Boiling Point	586.8°C at 760 mmHg